Anti-factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantation

Feng, I., Kurlansky, P. A., Powley, T. R., Hynds, M. A., Yang, C. G., Eisenberger, A., Hastie, J. M., Sutherland, L. D., Yuzefpolskaya, M., Colombo, P. C., Sayer, G. T., Uriel, N. Y., Naka, Y., & Takeda, K. (2024). Anti‐factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantation. Artificial Organs. Portico. https://doi.org/10.1111/aor.14885
Authors:
Iris Feng
Paul A Kurlansky
Tanner R Powley
Melissa A Hynds
Christine G Yang
Andrew Eisenberger
Jonathan M Hastie
Lauren D Sutherland
Melana Yuzefpolskaya
Paolo C Colombo
Gabriel T Sayer
Nir Y Uriel
Yoshifumi Naka
Koji Takeda
Affiliated Authors:
Iris Feng
Paul A Kurlansky
Tanner R Powley
Melissa A Hynds
Christine G Yang
Andrew Eisenberger
Jonathan M Hastie
Lauren D Sutherland
Melana Yuzefpolskaya
Paolo C Colombo
Gabriel T Sayer
Nir Y Uriel
Yoshifumi Naka
Koji Takeda
Author Keywords:
anti-factor xa
anticoagulation
heart failure
heartmate 3
left ventricular assist device
mechanical circulatory support
anti‐factor xa
Publication Type:
Article
Unique ID:
10.1111/aor.14885
PMID:
Publication Date:
Data Source:
PubMed

Record Created: